[Pathology and pathophysiology of inflammatory bowel diseases. Development of inflammatory bowel disease due to disruption of the intestinal immuno-regulatory mechanism].
暂无分享，去创建一个
[1] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[2] Wendy S. Garrett,et al. Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System , 2007, Cell.
[3] T. Hibi,et al. Abnormally Differentiated Subsets of Intestinal Macrophage Play a Key Role in Th1-Dominant Chronic Colitis through Excess Production of IL-12 and IL-23 in Response to Bacteria1 , 2005, The Journal of Immunology.
[4] Tetsuya Nakamura,et al. CD4+CD25bright T Cells in Human Intestinal Lamina Propria as Regulatory Cells1 , 2004, The Journal of Immunology.
[5] R Balfour Sartor,et al. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.
[6] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[7] H. Ogata,et al. Novel pathophysiological concepts of inflammatory bowel disease , 2005, Journal of Gastroenterology.
[8] R. Blumberg,et al. The immunology of mucosal models of inflammation. , 2002, Annual review of immunology.